New Blood: Former Novartis Exec Transitions to Rubius Therapeutics
New Red-Blood-Cell-Derived Therapies Are Poised to Launch Rubius into the Spotlight.
Improving Human Health: The Promise of Epigenetics
A New Perspective for Genomic Research from Prof. Shankar Balsubramanian
Translating Innovation into Therapies
Antimicrobial Resistance and Drug Commercialization Were Key Topics at the Recent ON Helix Conference in Cambridge, U.K.
Literature Review: Dielectrophoresis to the Fore
Old Methodology Resurrected to Allow Inexpensive Label-Free Separation of Cell Populations
U.S. Immigration Travel Ban
Many U.S. universities, academic centers, and health organizations have expressed deep concern about the Administration's executive order that has denied U.S. entry to people who bring unique expertise to the practice of medicine and the conduct of biomedical research. Much of the progress that has been achieved against a host of diseases has been fueled by researchers from all corners of the world, they say, adding that for this progress to continue it is going to require an even greater commitment to collaborations among international organizations, governments, public and private institutions, and individuals dedicated to this cause.